Literature DB >> 19702904

Endoscopic retrograde cholangiopancreatography in hepatic alveolar echinococcosis.

Gurkan Ozturk1, Kamil Yalcin Polat, Mehmet Ilhan Yildirgan, Bulent Aydinli, Sabri Selcuk Atamanalp, Unal Aydin.   

Abstract

BACKGROUND AND AIM: Hepatic alveolar echinococcosis (HAE) involves both the vascular and biliary structures of the liver. Endoscopic retrograde cholangiopancreatography (ERCP) is said to be an alternative for the diagnosis and treatment of biliary complications of HAE. We present here our experience with ERCP in HAE.
METHODS: We followed 13 patients who underwent ERCP for the treatment of biliary complications of HAE in the endoscopy unit of our clinic at Ataturk University School of Medicine, Erzurum between January 2002 and June 2008.
RESULTS: Eight men and five women were followed up. Mean age was 43.2 (24-64 years). All patients had non-resectable HAE. Indications for ERCP were biliary fistula in seven patients, obstructive jaundice in five patients and cholangitis in one patient. Endoscopic sphincterotomy (ES) was carried out in 12 patients, and in one patient with biliary leakage, a stent was inserted into the right hepatic branch. ERCP findings were dilated common bile duct, irregular narrowing and distortion of the common bile duct and common hepatic duct, communication with the cystic cavity or biliocutaneous fistula and complete disappearance of the biliary tree above the level of the common hepatic duct or hepatic bifurcation. In patients with biliary leakage, biliary drainage decreased only in two patients after ERCP and in patients with obstructive jaundice, the high bilirubin levels decreased in only one patient.
CONCLUSION: ERCP showed structural changes of the external biliary tract and ES has a limited effect on these changes and stents can be used in selected cases.

Entities:  

Mesh:

Year:  2009        PMID: 19702904     DOI: 10.1111/j.1440-1746.2009.05877.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Outcomes After Liver Resection for Hepatic Alveolar Echinococcosis: A Single-Center Cohort Study.

Authors:  Gaëtan-Romain Joliat; Emmanuel Melloul; David Petermann; Nicolas Demartines; Michel Gillet; Emilie Uldry; Nermin Halkic
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

2.  Hepatobiliary complications of alveolar echinococcosis: A long-term follow-up study.

Authors:  Tilmann Graeter; Franziska Ehing; Suemeyra Oeztuerk; Richard Andrew Mason; Mark Martin Haenle; Wolfgang Kratzer; Thomas Seufferlein; Beate Gruener
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

Review 3.  Non-surgical and non-chemical attempts to treat echinococcosis: do they work?

Authors:  Francesca Tamarozzi; Lucine Vuitton; Enrico Brunetti; Dominique Angèle Vuitton; Stéphane Koch
Journal:  Parasite       Date:  2014-12-23       Impact factor: 3.000

4.  Endoscopic Treatment of Biliary Stenosis in Patients with Alveolar Echinococcosis--Report of 7 Consecutive Patients with Serial ERC Approach.

Authors:  Marija Stojkovic; Thomas Junghanss; Mira Veeser; Tim F Weber; Peter Sauer
Journal:  PLoS Negl Trop Dis       Date:  2016-02-24

Review 5.  Role of the radiologist in the diagnosis and management of the two forms of hepatic echinococcosis.

Authors:  Paul Calame; Mathieu Weck; Andreas Busse-Cote; Eleonore Brumpt; Carine Richou; Celia Turco; Alexandre Doussot; Solange Bresson-Hadni; Eric Delabrousse
Journal:  Insights Imaging       Date:  2022-04-08

6.  Surgical treatment strategies for hepatic alveolar echinococcosis.

Authors:  L A Salm; A Lachenmayer; S F Perrodin; D Candinas; G Beldi
Journal:  Food Waterborne Parasitol       Date:  2019-04-05

7.  Evaluation of intrahepatic manifestation and distant extrahepatic disease in alveolar echinococcosis.

Authors:  Tilmann Graeter; Hai-Hua Bao; Rong Shi; Wen-Ya Liu; Wei-Xia Li; Yi Jiang; Julian Schmidberger; Eleonore Brumpt; Eric Delabrousse; Wolfgang Kratzer
Journal:  World J Gastroenterol       Date:  2020-08-07       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.